Mereo Biopharma Group Plc ADR (NASDAQ:MREO) Has Seen A Fall Of -30.50% This Year, Is It Still A Better Option Than Others?
In last trading session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) saw 1.57 million shares changing hands with its beta currently measuring 0.49. Company’s recent per